Meeting
2020 ASCO Virtual Scientific Program
Basal subtype and clinical estrogen receptor status of genomically basal breast tumors in Caucasian, African American, and Latin American patients.
Authors
Virginia G. Kaklamani
University of Texas San Antonio MD Anderson Cancer Center, San Antonio, TX
Virginia G. Kaklamani , Cathy Graham , Karen L. Tedesco , Abirami Sivapiragasam , Jennifer A. Crozier , Apurva N. Shah , Andrea Menicucci , Shiyu Wang , Michelle L Bolner , Erin Yoder , William Audeh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Clinical Trial Registration Number
NCT03053193
Citation
J Clin Oncol 38: 2020 (suppl; abstr 556)
DOI
10.1200/JCO.2020.38.15_suppl.556
Abstract #
556
Poster Bd #
48
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Molecular characterization of luminal breast tumors in African American women.
First Author: Yael Simons
Poster
2024 ASCO Breakthrough
Characterization of estrogen receptor mutant breast cancer in 3D cell culture.
First Author: Olivia Mayer
Poster
2024 ASCO Annual Meeting
Immune checkpoint inhibition for the treatment of metastatic breast cancer with high tumor mutational burden: Real world clinical and genomic correlates of response.
First Author: Nicholas Mai
Poster
2024 ASCO Annual Meeting
Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan.
First Author: Nicholas Mai